The Cancer Research Institute is inviting applicants for the CRI Technology Impact Award to support early-stage, high-risk technological innovations that could drive breakthroughs in cancer immunotherapy. This award specifically targets early-stage, pre-development concepts that have not yet been built or tested, encouraging bold, high-risk/high-reward ideas that could lay the foundation for transformative advances in the
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: